Abstract:Søegaard and colleagues 1 investigated whether prolonged exclusive breastfeeding (defined as ≥3 months) was associated with childhood cancer. Their register-based study included all children in the Danish National Child Health Register who were born between 2005 and 2018 and who had information about exclusive breastfeeding, defined as breast milk supplemented only by water or milk formula (maximum of once weekly). Until 2011, the reporting of exclusive breastfeeding in Denmark was voluntary (data available for 21% of births) but became mandatory in 2012 (data available for 62% of births). These data were linked to other population-based registers (Medical Birth Register, Civil Registration System, Population Education Register, Danish National Patient Register, and Danish Cancer Register). Children were followed up until diagnosis, loss to follow-up or emigration, death, age 15 years, or December 31, 2020 (ie, minimum of 2 years of follow-up). Using Cox proportional hazards regression and based on approximately 310 000 births and 1.6 million person-years of follow-up, the authors found that children who were exclusively breastfed for at least 3 months had a decreased risk of hematologic cancers (based on 124 cases), particularly B-cell precursor acute lymphoblastic leukemia (BCP-ALL; 74 cases), compared with those who were breastfed for less than 3 months. No such association was found for central nervous system (CNS) tumors (44 cases) or solid tumors (80 cases). The study was underpowered to investigate rarer cancers, such as acute myeloid leukemia (AML) or Hodgkin lymphoma. The study by Søegaard et al 1 is important, as it is, to my knowledge, the first population-based cohort study to report that prolonged exclusive breastfeeding may be associated with decreased risk of ALL. These findings support the existing literature based on case-control studies for both ALL 2 ,3 and CNS tumors. 3 ,4 A 2005 meta-analysis found an association of prolonged breastfeeding for more than 6 months with a decreased risk of ALL (13 studies) and acute nonlymphoblastic leukemia (9 studies) but no association with risk of CNS tumors (4 studies). 3 Similarly, using pooled data from multiple case-control studies, the Childhood Cancer and Leukemia International Consortium recently reported decreased risks of ALL (>10 000 cases) and AML (approximately 1700 cases) associated with breastfeeding for 4 months or more 2 but no association between CNS tumors and at least 6 months of breastfeeding. 4 Childhood cancer research is challenging because of the rarity of disease, leading to sample size issues. The consistency of findings between cohort and case-control studies shows that case-control studies can play an important role in identifying potential risk factors for rare diseases despite the risk of recall bias. The article by Søegaard et al 1 highlights some of the benefits of linking routinely collected population-based data for epidemiologic research, especially when the linkages move beyond the domain of conventional registers (births and deaths, hospitalizations, and disease-specific registers) to broader sources of data on child health. However, despite having data from over 300 000 children over 14 years, their study had insufficient case numbers to draw conclusions about some cancers, such as AML. Hopefully, this study can be replicated in other settings or pooled with other data for the benefits of statistical power. Both childhood cancers and exclusive breastfeeding are important child health issues. Childhood cancers remain a leading cause of early-life mortality, and the survivors can have long-term sequelae. According to the World Health Organization, breastfeeding is critical to achieving optimum growth and development, so it recommends exclusive breastfeeding (defined as breast milk only) for the first 6 months of life whenever possible. 5 Prolonged breastfeeding has a multitude of short- and long-term benefits for the infant in all economic settings (low, middle, and high income), including lower rates of infectious morbidity and likely lower rates of overweight and diabetes. 6 It also has advantages for the mother, such as lower rates of breast and ovarian cancers and type 2 diabetes. 7 All of these benefits equate to a strong economic benefit for the individual, family, and society. 6 Because of the existing evidence, the World Health Assembly has a goal of reaching a prevalence of exclusive breastfeeding during the first 6 months of life of 70% globally by 2030, but progress is slow. 6 Despite improvements in most regions, the current levels are still far below this target. 6 Between 2000 and 2018, the rates of any breastfeeding increased in high-income countries, but trends for exclusive breastfeeding cou -Abstract Truncated-

Does increased duration of exclusive breastfeeding protect against Helicobacter pylori Infection? The Newcastle Thousand Families Cohort Study at age 49-51 years

Relative Risk of Gastric Cancer Between Those with and Without Helicobacter Pylori Infection History in Japan

Adult cancer risk in women who were breastfed as infants: large UK prospective study

Being Breastfed in Infancy and Risk of Colorectal Cancer and Precursor Lesions

Exclusive Breastfeeding is Inversely Associated with Risk of Childhood Overweight in a Large Chinese Cohort.

Prolonged Exclusive Breastfeeding Duration Is Positively Associated With Risk Of Anemia In Infants Aged 12 Months

Relationship Between Infant Feeding and Infectious Illness: a Prospective Study of Infants During the First Year of Life.

Prolonged lactation reduces ovarian cancer risk in Chinese women.

Long‐term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population‐based cohort study

The relationship between breastfeeding and reported respiratory and gastrointestinal infection rates in young children

Exclusive Breastfeeding and Childhood Cancer Using Linked Data

Effects of Exclusive Breastfeeding Duration on Pneumonia Occurrence and Course in Infants Up to 6 Months of Age: A Case-Control Study

Causal associations between Helicobacter pylori infection and pregnancy and neonatal outcomes: a two-sample Mendelian randomization study

Breastfeeding Status and Duration and Infections, Hospitalizations for Infections, and Antibiotic Use in the First Two Years of Life in the ELFE Cohort

Breastfeeding Duration and Subsequent Risk of Mortality among US Women: A Prospective Cohort Study

Association between being breastfed in infancy and adult colorectal cancer risk among Japanese men and women

Breastfeeding duration is associated with favorable body composition and lower glycoprotein acetyls in later life

Breastfeeding duration is not associated with offspring inflammatory bowel disease risk in three population-based birth cohorts

Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population‐based ESTHER cohort study

Breastfeeding in Prevention of Postpartum Acute Pancreatitis

Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study